CEPI to Support Development of Self Amplifying mRNA Vaccine Technology for Use Against Disease X

OSLO, Norway CEPI to provide funding of up to US$3.6 million to advance the development of Gennova Biopharmaceutical’s self-amplifying thermostable […]

CEPI to Support Development of Self Amplifying mRNA Vaccine Technology for Use Against Disease X Read More »